RT Journal Article
SR Electronic
T1 Effectiveness of vaccines in preventing hospitalization due to COVID-19: A multicenter hospital-based case-control study, Germany, June 2021 to January 2022
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.06.28.22276303
DO 10.1101/2022.06.28.22276303
A1 Stoliaroff-Pepin, Anna
A1 Peine, Caroline
A1 Herath, Tim
A1 Lachmann, Johannes
A1 Perriat, Delphine
A1 Dörre, Achim
A1 Nitsche, Andreas
A1 Michel, Janine
A1 Grossegesse, Marica
A1 Hofmann, Natalie
A1 Rinner, Thomas
A1 Kohl, Claudia
A1 Brinkmann, Annika
A1 Meyer, Tanja
A1 Dorner, Brigitte G.
A1 Stern, Daniel
A1 Treindl, Fridolin
A1 Hein, Sascha
A1 Werel, Laura
A1 Hildt, Eberhard
A1 Gläser, Sven
A1 Schühlen, Helmut
A1 Isner, Caroline
A1 Peric, Alexander
A1 Ghouzi, Ammar
A1 Reichardt, Annette
A1 Janneck, Matthias
A1 Lock, Guntram
A1 Schaade, Lars
A1 Wichmann, Ole
A1 Harder, Thomas
YR 2022
UL http://medrxiv.org/content/early/2022/06/29/2022.06.28.22276303.abstract
AB We included 852 patients in a prospectively recruiting multicenter matched case-control study in Germany to assess vaccine effectiveness (VE) in preventing COVID-19-associated hospitalization (Delta-variant dominance). Two-dose VE was 89% (95%CI 84-93%) overall, 79% in patients with >2 comorbidities and 77% in adults aged 60-75 years. A third dose increased VE to >93% in all patient-subgroups.Competing Interest StatementS. G. received payment/honoraria from Astra Zeneca, Boehringer Ingelheim, Roche Pharma and Berlin Chemie, this had no influence on this work; all other authors reported no conflicts of interest.Funding StatementThe study is funded by the German Federal Ministry of HealthAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethikkommission der Charite, Chariteplatz 1, 10117 Berlin gave ethical approval for this work (EA1/063/23)I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors